Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Chemiluminescent Technology Market, By Type
7 Chemiluminescent Technology Market, By Application
7.3 Western Blotting
7.5 Combustion and Gas Analysis
7.6 Analysis of Organic and Inorganic Species
7.7 Forensic Science
8 Chemiluminescent Technology Market, By End User
8.2 Pharmaceutical and Biotechnology Companies
8.3 Academic and Research Institutes
8.4 Hospitals and Diagnostic Centers
9 Chemiluminescent Technology Market, By Region
9.2 North America
9.3.4 Rest of Europe (RoE)
9.5 Rest of The World (RoW)
10 Competitive Landscape
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Agreements & Partnerships
10.3.4 New Product Launches
10.3.5 Other Developments
11 Company Profiles
11.2 Thermo Fisher Scientific
11.3 F. Hoffmann-La Roche Ltd
11.4 Bio Rad Laboratories
11.5 Abbott Laboratories
11.6 Danaher Corporation
11.8 Analytik Jena AG
11.9 Siemens Healthineers
11.11 Agilent Technologies
Above Segmentation May Change During The Course of Planned Research Work.
Financials, Recent Developments Might Not Be Captured in Case of Unlisted Companies.
The global chemiluminescent technology market is expected to reach USD 14,286.8 million by 2023 from USD 10,983.3 million in 2018, growing at a CAGR of 5.4% from 2018 to 2023. Growing prevalence of infectious and chronic diseases; extensive use of immunoassay in oncology; technological advancements; cost-effectiveness & rapid analysis; and growth in the biotechnology and pharmaceutical sector are some of the growing factors for this market. Apart from this, increasing R&D investments in biotechnological industries; increasing government funding on cancer research and vaccine development are the major driving factors that fuel the chemiluminescent technology market over the forecast period.
North America dominates the chemiluminescent technology market with the U.S. accounting for a major market share. Increasing research on cancer and other infectious diseases, increasing government funding on cancer research are the major driving factors for this market in the region. For Instance, the U.S. government declared USD 5.21 billion to National Cancer Institute (NCI) for cancer research. Apart from this, presence of major players in the region is a main driver for chemiluminescent technology market. The Asian market is poised to grow at the highest CAGR during the forecast period owing to increasing government investments in the healthcare sector and improving healthcare facilities in the region. The rising focus of prominent players on the Asian chemiluminescent technology market is another factor driving its growth. Furthermore, emerging countries such as India and China provides opportunities for market players to generate more revenue.
Prominent players in the chemiluminescent technology market are ThermoFisher scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Bio Rad Laboratories (US), Abbott Laboratories (US), Danaher Corporation (US), Syngene (UK), Analytik Jena AG (Switzerland), Siemens healthineers (Germany), DiaSorin (Italy), Agilent Technologies (US)
This research report covers the global chemiluminescent technology market by type, application, end user, and geography.